Terms: = Liver cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Staging
8 results:
1. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract] [Full Text] [Related]
2. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract] [Full Text] [Related]
3. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
Zhou PY; Yang CP; Tang Z; Yi Y; Liu WR; Tian MX; Huang JL; Gan W; Jiang XF; Liu G; Wang H; Tao CY; Fang Y; Qu WF; Zhou C; Guan RY; Sun BY; Zhou YF; Song SS; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Gong GZ; Shi YH; Qiu SJ
Aging (Albany NY); 2019 Dec; 11(23):11111-11123. PubMed ID: 31829979
[TBL] [Abstract] [Full Text] [Related]
4. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical application of serum Golgi protein 73 in the diagnosis and progress of hepatocellular carcinoma].
Zhao Y; Li Y; Hu B; He X; Huang J; Zhan M; Lu L
Zhonghua Yi Xue Za Zhi; 2014 Feb; 94(5):390-2. PubMed ID: 24746091
[TBL] [Abstract] [Full Text] [Related]
6. The inflammation-based scores to predict prognosis of patients with hepatocellular carcinoma after hepatectomy.
Huang J; Xu L; Luo Y; He F; Zhang Y; Chen M
Med Oncol; 2014 Apr; 31(4):883. PubMed ID: 24535607
[TBL] [Abstract] [Full Text] [Related]
7. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
[TBL] [Abstract] [Full Text] [Related]
8. FDG PET as a prognostic predictor in the early post-therapeutic evaluation for unresectable hepatocellular carcinoma.
Higashi T; Hatano E; Ikai I; Nishii R; Nakamoto Y; Ishizu K; Suga T; Kawashima H; Togashi K; Seo S; Kitamura K; Takada Y; Uemoto S
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):468-82. PubMed ID: 19838700
[TBL] [Abstract] [Full Text] [Related]
